Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.2T | 2.0T | 2.3T | 2.1T |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | -28.0B | 37.1B | 47.2B | 35.8B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 0 | 0 | 0 | 0 |
Pretax income | 188.5B | 110.2B | 77.4B | 105.5B |
Tax provision | -232.1M | 97.4M | 64M | 70.7M |
Net income | 188.7B | 110.1B | 77.3B | 105.4B |
Basic EPS | — | 17.4 | 12.2 | 16.7 |
Diluted EPS | — | 17.4 | 12.2 | 16.7 |
Basic average shares | — | 6.3B | 6.3B | 6.3B |
Diluted average shares | — | 6.3B | 6.3B | 6.3B |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |